Kennedy Capital Management »

Protagonist Therapeutics shares owned by Kennedy Capital Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Kennedy Capital Management from 13F filings

Historical chart of Kennedy Capital Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Kennedy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Kennedy Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.6M 298k 28.93
2023-12-31 $7.0M 305k 22.93
2023-09-30 $5.3M 320k 16.68
2023-06-30 $11M 404k 27.62
2023-03-31 $7.6M 331k 23.00
2022-12-31 $3.8M 350k 10.91
2022-09-30 $835k 99k 8.43
2022-06-30 $784k 99k 7.91
2022-03-31 $2.3M 97k 23.68
2021-12-31 $3.6M 105k 34.20
2021-09-30 $2.0M 112k 17.72
2021-06-30 $3.2M 72k 44.88
2021-03-31 $2.0M 76k 25.90